相关实验视频

Updated: May 5, 2026

Vessel-sparing Excision and Primary Anastomosis

Vessel-sparing Excision and Primary Anastomosis

Published on: January 7, 2019

阴茎癌的 inguinal 淋巴结解剖的术后并发症相关的因素试验测试

Phatsinee Likitpanpisit¹, Satit Siriboonrid¹

¹Department of Surgery, Division of Urology, Phramongkutklao Hospital, Royal Thai Army, Bangkok, Thailand.

|November 27, 2024

概括

阴道淋巴结剖析用于阴茎癌的并发症率很高. 较高的体重指数和双边剖析增加了并发症的严重程度.

科学领域:

在瘤学瘤学.
手术瘤学手术瘤学
泌尿器科泌尿器科泌尿器科泌尿器科

背景情况:

阴道淋巴结解剖 (ILND) 是阴茎癌与可触摸或高风险淋巴结转移的标准.
ILND与显著的术后并发症有关,特别是伤口问题.
有限的研究存在于ILND并发症的风险因素.

研究的目的:

为了确定阴茎癌ILND后30天术后并发症的患病率.
为了确定与这些术后并发症相关的危险因素.

主要方法:

对因阴茎癌而接受ILND的患者 (2012-2022) 病历的回顾性审查.
用修改的Clavien-Dindo分类来评估并发症.
顺序逻辑回归和多变量分析确定了风险变量.

主要成果:

60名患者接受了ILND;60%的患者经历了并发症 (例如,伤口感染,枯,,淋巴细胞,).
更高的并发症等级与增加的体重指数 (BMI),糖尿病,美国麻醉学会 (ASA) 的更高分类,激进ILND和双边ILND相关.
多变量分析将更高的并发症等级与BMI和双边ILND联系起来.

结论:

阴茎癌的ILND与高发生率的术后并发症有关.
体重指数和执行双边ILND是导致更严重并发症的重要危险因素.

关键词:

复杂化复杂化复杂化复杂化 inguinal 淋巴结剖析 inguinal 淋巴结剖析淋巴结剖析阴茎癌是阴茎癌的一种疾病.风险因素的风险因素是什么

更多相关视频

Microscopic Replantation of Penile Glans Amputation Due to Circumcision

Microscopic Replantation of Penile Glans Amputation Due to Circumcision

Published on: June 3, 2022

Combination of High Ligation and Intraoperative Embolization using Polidocanol for Treatment of Varicoceles

Combination of High Ligation and Intraoperative Embolization using Polidocanol for Treatment of Varicoceles

Published on: December 22, 2023

相关概念视频

Peripheral Artery Disease V: Postoperative Nursing Management

Peripheral Artery Disease V: Postoperative Nursing Management

During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...